MSD-ERTUGLIFLOZIN-METFORMIN 7.5/1000 ertugliflozin/metformin hydrochloride 7.5 mg/1000 mg film-coated tablet blister pack

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

metformin hydrochloride, Quantity: 1000 mg; ertugliflozin pyroglutamic acid, Quantity: 9.713 mg (Equivalent: ertugliflozin, Qty 7.5 mg)

Доступно од:

Merck Sharp & Dohme (Australia) Pty Ltd

Фармацеутски облик:

Tablet, film coated

Састав:

Excipient Ingredients: sodium lauryl sulfate; povidone; magnesium stearate; crospovidone; Carnauba Wax; microcrystalline cellulose; titanium dioxide; hypromellose; hyprolose; iron oxide red

Пут администрације:

Oral

Јединице у пакету:

56, 14

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

MSD-ERTUGLIFLOZIN-METFORMIN (ertugliflozin and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and metformin is appropriate. [see 5.1 PHARMACODYNAMIC PROPERTIES, Clinical trials and 4.2 DOSE AND METHOD OF ADMINISTRATION]

Резиме производа:

Visual Identification: Red, oval, film-coated tablets debossed with '7.5/1000' on one side and plain on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Статус ауторизације:

Licence status A

Датум одобрења:

2018-05-17